Skip to main content
辰光医疗 logo

辰光医疗 — Investor Relations & Filings

Ticker · 920300 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 390 across all filing types
Latest filing 2024-04-22 Audit Report / Informat…
Country CN China
Listing Beijing Stock Exchange 920300

About 辰光医疗

http://www.shanghaicg.net/

Shanghai Chenguang Medical Technologies Co., Ltd. specializes in the research, development, and manufacturing of core components for Magnetic Resonance Imaging (MRI) systems. The product portfolio includes high-performance radiofrequency (RF) coils, superconducting magnets, and gradient coils designed for clinical, preclinical, and veterinary applications. The company focuses on high-field and ultra-high-field MRI technology, providing customized hardware solutions and integrated components to global imaging equipment manufacturers. Its technical capabilities encompass electromagnetic simulation, structural design, and precision manufacturing of specialized imaging hardware.

Recent filings

Filing Released Lang Actions
内部控制自我评价报告
Audit Report / Information Classification · 95% confidence The document is titled as an "内部控制自我评价报告" which translates to "Internal Control Self-Evaluation Report". It is a detailed report on the company's internal control system, its principles, objectives, execution, and evaluation results as of December 31, 2023. The document includes extensive descriptions of governance, risk management, control activities, information and communication, internal supervision, and other internal control aspects. It also discusses the identification and classification of internal control deficiencies and the company's corrective actions. The document is not a financial statement or an annual report but rather a specialized report on internal control effectiveness and compliance with regulatory internal control standards. This fits the definition of an Audit Report / Information (AR), which includes standalone audit reports and applied accounting principles and internal control evaluations, excluding full annual reports. The document is substantive and detailed, not a mere announcement or certification, so it is not classified as Regulatory Filings (RNS) or Report Publication Announcement (RPA). Therefore, the appropriate classification is AR with high confidence. FY 2023
2024-04-22 Chinese
募集资金存放与实际使用情况的专项报告
Capital/Financing Update Classification · 95% confidence The document is titled as a "专项报告" (special report) on the storage and actual use of raised funds by Shanghai Chenguang Medical Technology Co., Ltd. It details the issuance of shares, the amount of funds raised, the management and use of these funds, including specific bank accounts, investment projects, and compliance with regulatory requirements. It includes auditor verification and sponsor opinions on the use of the raised funds. The document is focused on the management and use of capital raised through equity issuance, not a general financial report or earnings release. It is a detailed report on capital raising and fund usage, which fits the category of Capital/Financing Update (CAP). The document length is over 8,000 characters and contains substantive financial and operational details about the raised funds, their management, and usage, not just an announcement or a brief summary. Therefore, it is not a Report Publication Announcement (RPA) or Regulatory Filing (RNS).
2024-04-22 Chinese
关于公司拟续聘中汇会计师事务所（特殊普通合伙）为公司2024年年度审计机构的公告
Audit Report / Information Classification · 95% confidence The document is an announcement regarding the proposed reappointment of an accounting firm (中汇会计师事务所) as the auditor for the 2024 fiscal year. It details the auditor's background, audit fees, independence, and the approval process by the board and audit committee. There are no actual financial statements or audit reports included, only information about the auditor appointment and related procedures. The document length is 2696 characters, which is relatively short and consistent with an announcement rather than a full audit report. Therefore, this document is best classified as an Audit Report / Information announcement (AR) because it relates specifically to audit information and auditor appointment, but it is not a full annual report or audit report itself. However, given the short length and nature, it could also be considered a Regulatory Filing (RNS), but since it focuses on audit information, AR is more precise. FY 2024
2024-04-22 Chinese
2023年度会计师事务所履职情况评估报告
Audit Report / Information Classification · 95% confidence The document is titled '2023 年度会计师事务所履职情况评估报告' which translates to '2023 Annual Evaluation Report on the Performance of the Accounting Firm'. It discusses the appointment and evaluation of the auditing firm for the company's 2023 annual audit. The content focuses on the audit firm's qualifications, independence, and performance in auditing the company's 2023 financial statements. It does not contain the actual financial statements or detailed financial data but rather an assessment of the audit firm's work. The document length is short (1328 characters) and it is an evaluation report related to audit activities, not the audit report itself or the full annual report. Therefore, it fits best under the category of Audit Report / Information (AR), which includes standalone audit reports and evaluations of audit firms' performance. FY 2023
2024-04-22 Chinese
独立董事2023年度述职报告（方龙）
Board/Management Information Classification · 95% confidence The document is titled as an independent director's 2023 annual duty report for Shanghai Chenguang Medical Technology Co., Ltd. It details the director's attendance at board and committee meetings, independent opinions on various company matters, and fulfillment of special duties. The content focuses on governance activities and the director's role rather than financial results or audit findings. The document length is 3251 characters, which is relatively short and does not contain financial statements or detailed financial data. It is a report on board/management information, specifically about the independent director's duties and opinions during the year. Therefore, the most appropriate classification is Board/Management Information (MANG).
2024-04-22 Chinese
关于召开2023年年度股东大会通知公告（提供网络投票）
AGM Information Classification · 100% confidence The document is a detailed notice about the convening of the 2023 Annual General Meeting (AGM) of Shanghai Chunguang Medical Technology Co., Ltd. It includes information about the meeting date, voting methods, agenda items to be discussed, and procedural details. The document explicitly states it is a notice for the 2023 annual shareholders' meeting and lists the various proposals to be voted on during the meeting. It does not contain the actual annual report, audit report, or financial statements but rather the announcement and details about the AGM itself. Therefore, this document fits the category of AGM Information (AGM-R). The document length is over 5,000 characters and contains substantive content about the AGM, not just a brief announcement or link to a report, so it is not a Report Publication Announcement (RPA).
2024-04-22 Chinese

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.